Enanta Pharmaceuticals
ENTA
#7732
Rank
ยฃ0.31 B
Marketcap
ยฃ10.94
Share price
3.64%
Change (1 day)
98.77%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of September 2025 : ยฃ48.81 Million

According to Enanta Pharmaceuticals 's latest financial reports the company has ยฃ48.81 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2025-09-30$ยฃ48.14 M-50.01%
2024-09-30$ยฃ96.3 M-45.81%
2023-09-30$ยฃ0.17 B-38.47%
2022-09-30$ยฃ0.28 B-2.61%
2021-09-30$ยฃ0.29 B-15.92%
2020-09-30$ยฃ0.35 B-6.28%
2019-09-30$ยฃ0.37 B24.64%
2018-09-30$ยฃ0.30 B34.07%
2017-09-30$ยฃ0.22 B8.13%
2016-09-30$ยฃ0.20 B33.37%
2015-09-30$ยฃ0.15 B70.31%
2014-09-30$ยฃ91.68 M34.35%
2013-09-30$ยฃ68.24 M150.5%
2012-09-30$ยฃ27.24 M93.8%
2011-09-30$ยฃ14.05 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
ยฃ61.23 B 125,347.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ29.36 B 60,049.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
-ยฃ4.99 Billion-10,316.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ14.60 B 29,817.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ34.64 B 70,872.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ15.16 B 30,961.39%๐Ÿ‡บ๐Ÿ‡ธ USA